Skip to content
DE
Enzyme

Alpha-Galactosidase

Alpha-galactosidase is an enzyme that breaks down certain complex sugars in beans and some vegetables. Supplement versions are usually produced by fungi.

Gut Health

What it is studied for

The strongest rated effects first. Bars show the size of the effect, the letter grades the evidence, and each rating lists the studies behind it.

Bloating & gas reliefGut HealthStrongA3 studies
Gut healthSmallCNo linked study
Microbiome healthGut HealthSmallCNo linked study
Food SensitivitiesGut HealthSmallCNo linked study
Digestive sensitivityGut HealthSmallCNo linked study
Every rating with its studiesGrouped by health goal, with the publications behind each rating

Could an enzyme make beans easier to tolerate?

Alpha-galactosidase helps break down galacto-oligosaccharides, or GOS, fermentable carbohydrates found in foods such as legumes. The idea is to improve tolerance of the food that contains them. It is a targeted approach to a food trigger, rather than a general treatment for every cause of bloating. 1

Key studies

The most recent publications linked to Alpha-Galactosidase's ratings.

A randomized double‐blind placebo‐controlled crossover pilot study: Acute effects of the enzyme α‐galactosidase on gastrointestinal symptoms in irritable bowel syndrome patients2021Increasing Symptoms in Irritable Bowel Symptoms With Ingestion of Galacto-Oligosaccharides Are Mitigated by α-Galactosidase Treatment2018The effect of oral alpha-galactosidase on intestinal gas production and gas-related symptoms.2007

Why people take it

Essential Health22.5%
Gut Health22.4%
Immune Support17.5%
Energy11.8%
Detox11.7%
Fitness3.9%

SuppCo community snapshot, 2026-09-28. Reasons for use are not evidence that it works.

Questions people ask

Does it digest every FODMAP?

No. The evidence discussed here concerns GOS. The target carbohydrate and a person’s sensitivity to it are central to the rationale. 1

Does more enzyme necessarily work better?

No. A higher-dose pilot study found no benefit over placebo with its test meals. Different food exposures and participants limit comparisons between studies. 2 3

Is it a treatment for all IBS symptoms?

The encouraging trial result was concentrated in GOS-sensitive participants. Another IBS trial found no symptom advantage, so a general benefit cannot be assumed. 2 3

Sources